Related references
Note: Only part of the references are listed.Dependence on the MUC1-C Oncoprotein in Non-Small Cell Lung Cancer Cells
Deepak Raina et al.
MOLECULAR CANCER THERAPEUTICS (2011)
MUC1 expression in thymic epithelial tumors: MUC1 may be useful marker as differential diagnosis between type B3 thymoma and thymic carcinoma
Kyoichi Kaira et al.
VIRCHOWS ARCHIV (2011)
The membrane-bound mucins: From cell signalling to transcriptional regulation and expression in epithelial cancers
Nicolas Jonckheere et al.
BIOCHIMIE (2010)
Mucins and CD56 as markers of tumour invasion and prognosis in periampullary cancer
M. M. Aloysius et al.
BRITISH JOURNAL OF SURGERY (2010)
Angiogenesis Inhibitors: Current Strategies and Future Prospects
Kristina M. Cook et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Global Patterns of Cancer Incidence and Mortality Rates and Trends
Ahmedin Jemal et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer
N. Khodarev et al.
ONCOGENE (2010)
RKTG inhibits angiogenesis by suppressing MAPK-mediated autocrine VEGF signaling and is downregulated in clear-cell renal cell carcinoma
Y. Zhang et al.
ONCOGENE (2010)
Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells
Esther S. Shao et al.
BLOOD (2009)
Functional targeting of the MUC1 oncogene in human cancers
Donald W. Kufe
CANCER BIOLOGY & THERAPY (2009)
MUC1, a New Hypoxia Inducible Factor Target Gene, Is an Actor in Clear Renal Cell Carcinoma Tumor Progression
Sebastien Aubert et al.
CANCER RESEARCH (2009)
MUC1-Induced Transcriptional Programs Associated with Tumorigenesis Predict Outcome in Breast and Lung Cancer
Nikolai N. Khodarev et al.
CANCER RESEARCH (2009)
Overexpression and altered glycosylation of MUC1 in malignant mesothelioma
J. Creaney et al.
BRITISH JOURNAL OF CANCER (2008)
Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer
Matthias Woenckhaus et al.
HUMAN PATHOLOGY (2008)
Interaction of MUC1 with β-catenin modulates the WNT target gene cyclinD1 in H pylori-induced gastric cancer
Gopal Udhayakumar et al.
MOLECULAR CARCINOGENESIS (2007)
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer
Alan Sandler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Akt down-regulates ERK1/2 nuclear localization and angiotensin II-induced cell proliferation through PEA-15
Marianne Gervais et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Clinical features of 5,628 primary lung cancer patients - Experience at Mayo clinic from 1997 to 2003
P Yang et al.
CHEST (2005)
Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents
J Ren et al.
CANCER CELL (2004)
MUC1 tyrosine phosphorylation activates the extracellular signal-regulated kinase
HH Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Adeno-associated viral vector delivers card iac-specific and hypoxia-inducible VEGF expression in ischemic mouse hearts
H Su et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Akt and hypoxia-inducible factor-1 independently enhance tumor growth and angiogenesis
AM Arsham et al.
CANCER RESEARCH (2004)
Pro-inflammatory cytokines up-regulate MUC1 gene expression in oral epithelial cells
X Li et al.
JOURNAL OF DENTAL RESEARCH (2003)
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
JH Schiller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Mechanisms of angiogenesis and arteriogenesis
P Carmeliet
NATURE MEDICINE (2000)